Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 2.81B INR in the quarter ending June 30, 2025, a decrease of -21.79%. This brings the company's revenue in the last twelve months to 15.92B, down -3.49% year-over-year. In the fiscal year ending March 31, 2025, Nectar Lifesciences had annual revenue of 16.70B, down -0.87%.

• Revenue (ttm): 15.92B
• Revenue Growth: -3.49%
• P/S Ratio: 0.22
• Revenue / Employee: 9.44M
• Employees: 1,686
• Market Cap: 3.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	16.70B	-145.97M	-0.87%
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%
Mar 31, 2021	15.43B	-8.23B	-34.78%